Key result
Novel PET and SPECT radiotracers visualize cellular disease processes to facilitate personalized patient care.
Why the study?
Traditional cardiovascular imaging techniques assess structural and functional aspects but often fall short in providing direct insights into disease activity.
Molecular cardiovascular imaging using novel radiotracers and advanced PET/SPECT scanners holds promise for precision medicine by providing direct insights into disease activity at the cellular level.
Supports molecular imaging exploration for precision cardiology; leaves open needs for prospective outcome validation.
Cardiovascular imaging has rapidly advanced over the past decades. Traditional imaging techniques such as echocardiography, computed tomography, and cardiovascular magnetic resonance are essential for assessing the structural and functional aspects of the cardiovascular system but often fall short in providing direct insights into disease activity. This gap is increasingly being bridged by molecular nuclear imaging techniques, including positron emission tomography and single-photon emission computed tomography, which enable the visualization of disease processes at the molecular and cellular levels. This review highlights the role of cardiovascular molecular imaging, emphasizing its current and potential applications in diagnosing and managing cardiovascular disease. With advancements in positron emission tomography scanners, novel radiotracers, and sophisticated imaging software, molecular imaging is set to play an essential role in precision medicine by enhancing our understanding of disease mechanisms, accelerating the development of targeted therapies, and facilitating personalized patient care.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2024) conducted a review in Cardiovascular disease. Molecular nuclear imaging techniques (PET and SPECT) was evaluated. Molecular nuclear imaging techniques, including PET and SPECT with novel radiotracers, enable visualization of disease processes at the cellular level to facilitate personalized patient care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: